Future Medicine India – Doctor’s Interviews Medical devices and gadgets Straight Talk Archives | Future Medicine India

Straight Talk

“Few nations have taken steps to address vaccine uncertainty and hesitancy”

In an interaction with FM, Anjali highlights the need to get as many people vaccinated as quickly as possible against the pandemic. 

FM
Read More..

Mucormycosis can spread rapidly in COVID-19 patients with uncontrolled diabetes

Since mucormycosis is highly dangerous, killing between 46% to 96% of the patients, and often leads to complete blindness if not death, it is better to prevent it by taking due care in treatment protocol and maintaining proper hygiene in ICUs and the whole hospital environment, says Dr V Mohan

Prapti Shah

“Our call to countries is to do bi-directional testing for TB and COVID-19”

Dr Lucica Ditiu, Executive Director of Stop TB Partnership, speaks about the international body’s ambitious goal to make the world free of the curable infectious disease and how the programme has been impacted by various challenges, including the COVID-19 pandemic.

S Harachand

“Biobanks have enabled healthcare innovation”

Sapien was established in a visionary partnership with Apollo Hospitals, a pan-India network of 71 multi-specialty hospitals that allowed us to create a multi-centric, pan-India biobank covering all diseases. We started with one hospital in 2012 and now have a pan-India footprint of more than 20.

Prapti Shah

‘No need to wait till the end to provide the benefits of palliative care’

In an interaction with S Harachand, Prof Harding says that there is no need to wait until a patient is dying to introduce the benefits of palliative care, as integrating palliative care much earlier into the treatment cycle of a terminally ill patient will not only improve outcomes but can at times even prolong the life of the patient.

S Harachand

“Data privacy is the most critical issue that Viveo wants to ensure”

In conversation with Divya Choyikutty, Kallo explains, Raul Kallo is the CEO & Founder of Viveo, his company’s big plans for India and what makes Viveo Health different.

Divya Choyikutty

“PATHOLOGY TAUGHT IN INDIA HAS VERY LITTLE EMPHASIS ON CLINICAL REASONING AND APPLICATION”

we are going through an interesting period as these developments have led to positive changes in pathology education, training and practice, ultimately benefiting the patients, says Dr Shivayogi Bhusnurmath

C H Unnikrishnan